We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.94%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.09B
AUM Growth
+$15.8M
(+0.76%)
Cap. Flow
-$86M
Cap. Flow
% of AUM
-4.12%
Top 10 Holdings %
Top 10 Hldgs %
18.08%
Holding
266
New
20
Increased
45
Reduced
134
Closed
56
Top Buys
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$18.8M |
| 2 |
Tenable Holdings
TENB
|
+$16.8M |
| 3 |
LivaNova
LIVN
|
+$14M |
| 4 |
Fabrinet
FN
|
+$13.9M |
| 5 |
ICU Medical
ICUI
|
+$11.8M |
Top Sells
| 1 |
ProFrac Holding
ACDC
|
+$26.1M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$21.4M |
| 3 |
Customers Bancorp
CUBI
|
+$16M |
| 4 |
MACOM Technology Solutions
MTSI
|
+$14.6M |
| 5 |
PRFT
Perficient Inc
PRFT
|
+$13.2M |
Sector Composition
| 1 | Healthcare | 31.06% |
| 2 | Technology | 16.79% |
| 3 | Industrials | 15.69% |
| 4 | Consumer Discretionary | 14.06% |
| 5 | Financials | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Churchill Downs
CHDN
$5.85B
| $44.9M | 2.15% |
349,484
-6,710
| -2% | -$810K |
|
2
Super Micro Computer
SMCI
$15.6B
| $42.6M | 2.04% |
3,999,990
-924,160
| -19% | -$8.34M |
|
3
Lantheus
LNTH
$7B
| $42.4M | 2.03% |
513,969
+87,930
| +21% | +$5.67M |
|
4
Simply Good Foods
SMPL
$980M
| $41.6M | 1.99% |
1,045,276
-12,514
| -1% | -$462K |
|
5
Shift4
FOUR
$3.99B
| $41M | 1.97% |
540,640
-7,728
| -1% | -$498K |
|
6
Freshpet
FRPT
$2.78B
| $34.8M | 1.67% |
525,810
-8,308
| -2% | -$510K |
|
7
Treace Medical Concepts
TMCI
$279M
| $34.3M | 1.65% |
1,363,453
+175,207
| +15% | +$4.11M |
|
8
Transmedics
TMDX
$2.56B
| $32.6M | 1.56% |
430,552
-132,115
| -23% | -$9.14M |
|
9
Planet Fitness
PLNT
$4.14B
| $31.9M | 1.53% |
411,206
-6,530
| -2% | -$522K |
|
10
Carpenter Technology
CRS
$27.7B
| $30.8M | 1.48% |
687,973
-9,350
| -1% | -$426K |
|
|
11
Tenable Holdings
TENB
$4.4B
| $30.3M | 1.46% |
638,763
+394,812
| +162% | +$16.8M |
|
12
NeoGenomics
NEO
$1.9B
| $29.1M | 1.39% |
1,669,324
-432,243
| -21% | -$6.16M |
|
|
RETA
13
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $28.6M | 1.37% |
314,621
-365,151
| -54% | -$21.4M |
|
14
Amylyx Pharmaceuticals
AMLX
$1.97B
| $28.5M | 1.37% |
972,835
+135,926
| +16% | +$4.72M |
|
15
Acadia Pharmaceuticals
ACAD
$4.38B
| $28.2M | 1.35% |
1,496,560
+174,414
| +13% | +$3.32M |
|
16
Exponent
EXPO
$3.05B
| $28.2M | 1.35% |
282,461
+14,523
| +5% | +$1.48M |
|
|
EVRI
17
DELISTED
Everi Holdings
EVRI
| $28.1M | 1.35% |
1,640,309
-384,969
| -19% | -$6.66M |
|
18
Merit Medical Systems
MMSI
$4.41B
| $28.1M | 1.35% |
380,019
-142,151
| -27% | -$9.97M |
|
|
19
MACOM Technology Solutions
MTSI
$20.4B
| $27.3M | 1.31% |
384,827
-216,733
| -36% | -$14.6M |
|
20
Jack in the Box
JACK
$286M
| $27M | 1.29% |
308,028
-4,587
| -1% | -$363K |
|
|
NVEE
21
DELISTED
NV5 Global
NVEE
| $26.6M | 1.27% |
1,022,596
-10,596
| -1% | -$318K |
|
|
BWIN
22
Baldwin Insurance Group
BWIN
$2.66B
| $26.1M | 1.25% |
1,026,490
-90,519
| -8% | -$2.51M |
|
|
MODN
23
DELISTED
MODEL N, INC.
MODN
| $25.8M | 1.24% |
769,683
+50,083
| +7% | +$1.83M |
|
24
Kratos Defense & Security Solutions
KTOS
$8.63B
| $25.3M | 1.21% |
1,878,598
-13,994
| -0.7% | -$167K |
|
25
Northern Oil and Gas
NOG
$2.31B
| $25M | 1.2% |
824,515
-25,207
| -3% | -$785K |
|
Similar funds
AWE
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
Emerald Advisers's Q1 2023 Portfolio in Review
As of Q1 2023, Emerald Advisers held 266 positions worth $2.09B, up 0.76% from $2.07B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Advisers withdrew a net $86M in Q1 2023, closing 56 positions and reducing 134 holdings. Its most notable exit was ProFrac Holding, an estimated $26.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Industrials.
Against the trend, Emerald Advisers opened a new position in LivaNova worth $12.1M.
- Emerald Advisers's largest Q1 2023 buy was LivaNova: 277,388 shares worth $12.1M.
- Emerald Advisers added most to Madrigal Pharmaceuticals in Q1 2023, an estimated $18.8M increase.
- Emerald Advisers's biggest Q1 2023 reduction was Reata Pharmaceuticals, Inc. Class A Common Stock, cutting an estimated $21.4M.
- Emerald Advisers fully exited ProFrac Holding in Q1 2023, selling an estimated $26.1M.
- Emerald Advisers's ten largest holdings make up 18% of its $2.09B portfolio in Q1 2023.
- Emerald Advisers opened 20 new positions and closed 56 in Q1 2023.
- Emerald Advisers's portfolio value rose 0.76% quarter-over-quarter to $2.09B.
Based on Emerald Advisers's 13F filing for Q1 2023, filed 4 May 2023.